GobyMeds vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: GobyMeds scores higher on our rubric, 8.4/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - $179 first month, then $299/mo →or find your match

GobyMeds beats MEDVi overall, scoring 8.4/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: GobyMeds is from $99/mo; MEDVi is $179 first month, then $299/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at GobyMeds and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

GobyMeds

#2 of 54

8.4/10

Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.

Visit GobyMeds

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	GobyMeds	MEDVi
Why each one	The best value in compounded GLP-1s, $169/mo standard monthly ($99/mo on the 3-month starter bundle) with a user experience and support quality that rivals platforms charging 50-75% more.	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.
Our Score	8.4/10	5.7/10
Headline Price	from $99/mo	$179 first month, then $299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#2	#46
Get started	Visit GobyMeds	Visit MEDVi

Pros & Cons Compared

GobyMeds

Pros

+$169/mo standard monthly rate, or $99/mo on the 3-month starter bundle, among the most affordable for a full-service compounded program
+Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
+Modern patient portal with real-time order tracking and easy provider messaging
+Quick onboarding, most patients approved and shipped within 48 hours of enrollment

Cons

−Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story
−Newer company with less track record than established players like Ro or Hims
−No insurance billing and no superbills for FSA/HSA reimbursement

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

GobyMeds edges out MEDVi with a score of 8.4/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: GobyMeds is from $99/mo; MEDVi is $179 first month, then $299/mo.